[5-fluorouracil in high doses. Principles and toxicity]

Area of Science:

• Oncology
• Gastroenterology
• Pharmacology

Context:

• 5-fluorouracil (5FU) is a cornerstone chemotherapy for gastrointestinal (GI) cancers.
• Optimizing 5FU's therapeutic index is crucial for improving patient outcomes.
• Managing chemotherapy-induced toxicity is a significant clinical challenge.

Purpose:

• To evaluate the safety and efficacy of high-dose 5-fluorouracil (5FU) combined with allopurinol in patients with advanced gastrointestinal cancer.
• To assess the toxic effects associated with this intensified chemotherapy regimen.
• To determine if this combination therapy offers a better therapeutic index compared to standard protocols.

Summary:

• Twenty patients with advanced gastrointestinal cancer received high-dose 5FU (3 gr./m2) concurrently with allopurinol to prevent normal tissue toxicity.
• The study monitored and evaluated the toxic effects experienced by these patients.
• Results indicated that the combination of high-dose 5FU and allopurinol was safely administered.

Impact:

• This study suggests a potentially safer and more effective method for utilizing high-dose 5FU in GI cancer treatment.
• The findings may inform clinical practice regarding the use of allopurinol as a protective agent against 5FU toxicity.
• Further research could explore long-term outcomes and broader applicability of this regimen.